结肠癌放射学T分期:临床实践中重新燃起的兴趣
本文综述CT、CT结肠成像、MRI与FDG PET-CT在结肠癌T分期中的表现,并简要讨论N分期。随着临床试验探索将新辅助治疗从直肠扩展至结肠,准确的放射学T分期预计将显著影响结肠癌新辅助治疗与手术管理的临床决策。
要点
- 结肠癌诊断与转移分期长期以结肠镜和CT为标准,T、N分期常在手术切除时完成。
- 近期临床试验探索将新辅助治疗从直肠扩展至结肠其余部位,重新引发对放射学T分期的兴趣。
- 本文综述CT、CT结肠成像、MRI与FDG PET-CT用于结肠癌分期的表现,并简要讨论N分期。
核心结论
- 随着临床试验探索将新辅助治疗从直肠扩展至结肠其余部位,结肠癌治疗当前与未来格局正在演变,对放射学在结肠癌原发T分期中作用的评估重新燃起兴趣。
- 预计准确的放射学T分期将显著影响未来关于结肠癌新辅助治疗与手术管理的临床决策。
研究设计与样本
- 综述类文章,复习CT、CT结肠成像、MRI与FDG PET-CT用于结肠癌分期的表现,并简要讨论N分期。
临床应用与阅片要点
- 本文综述CT、CT结肠成像、MRI与FDG PET-CT在结肠癌分期中的表现,供临床实践参考。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Radiologic imaging, especially MRI, has long been the mainstay for rectal cancer staging and patient selection for neoadjuvant therapy prior to surgical resection. In contrast, colonoscopy and CT have been the standard for colon cancer diagnosis and metastasis staging with T and N staging often performed at the time of surgical resection. With recent clinical trials exploring the expansion of the use of neoadjuvant therapy beyond the anorectum to the remainder of the colon, the current and future state of colon cancer treatment is evolving with a renewed interest in evaluating the role radiology may play in the primary T staging of colon cancer. The performance of CT, CT colonography, MRI, and FDG PET-CT for colon cancer staging will be reviewed. N staging will also be briefly discussed. It is expected that accurate radiologic T staging will significantly impact future clinical decisions regarding the neoadjuvant versus surgical management of colon cancer.
引用
- Chang, Kim, Lalani, et al. Radiologic T staging of colon cancer: renewed interest for clinical practice. Abdom Radiol (NY). 2023. PMID: 37277570. doi:10.1007/s00261-023-03904-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。